Selective drug metabolite trace analysis by very high-volume injections and heartcut two-dimensional (2D)-ultrahigh performance liquid chromatography (UHPLC).
Heartcut 2D-LC
Large volume injection
Online preconcentration
Trace analysis
Journal
Journal of chromatography. A
ISSN: 1873-3778
Titre abrégé: J Chromatogr A
Pays: Netherlands
ID NLM: 9318488
Informations de publication
Date de publication:
13 Sep 2019
13 Sep 2019
Historique:
received:
18
01
2019
revised:
05
04
2019
accepted:
23
04
2019
pubmed:
3
5
2019
medline:
25
7
2019
entrez:
4
5
2019
Statut:
ppublish
Résumé
The application of two-dimensional liquid chromatography (2D-LC) is gradually growing also in the area of metabolite profiling and identification. The current contribution describes a heartcut 2D-UHPLC configuration that is applied in support of drug metabolism studies in development. The setup applies four LC columns: two analytical UHPLC columns to perform the first and second dimension separations, which are both preceded by a short HPLC column operated as trapping column. The first HPLC column allows a significant online preconcentration by large volume injection. The second short HPLC column is placed between the first and second dimension columns and enables the selection of orthogonal conditions in the second dimension independent of the first dimension making the heartcutting 2D approach more generic. The value of the setup was demonstrated with selective ultraviolet chromatograms obtained for the two major hydroxylated metabolites of atorvastatin separating them from a very high biological background, originating from an injection of 4 mL feces extract, by heartcut 2D-LC. In a second application, the main metabolite of imipramine was baseline separated from some minor metabolites that were co-eluting in the first dimension, allowing accurate and sensitive quantification. A quantification limit in the attogram/mL range was achieved thanks to the injection of 200 mL diluted urine, corresponding to 100 mL urine on column.
Identifiants
pubmed: 31047660
pii: S0021-9673(19)30449-2
doi: 10.1016/j.chroma.2019.04.064
pii:
doi:
Substances chimiques
Pharmaceutical Preparations
0
Atorvastatin
A0JWA85V8F
Imipramine
OGG85SX4E4
Types de publication
Journal Article
Langues
eng
Pagination
164-170Informations de copyright
Copyright © 2019 Elsevier B.V. All rights reserved.